Patrick James Orme

Array ( [id] => 6796387 [patent_doc_number] => 20030175260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Novel DNA and a process for its use' [patent_app_type] => new [patent_app_number] => 10/310671 [patent_app_country] => US [patent_app_date] => 2002-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 25010 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175260.pdf [firstpage_image] =>[orig_patent_app_number] => 10310671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6797511 [patent_doc_number] => 20030176385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Antisense modulation of protein expression' [patent_app_type] => new [patent_app_number] => 10/305810 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 19758 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176385.pdf [firstpage_image] =>[orig_patent_app_number] => 10305810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6825586 [patent_doc_number] => 20030236208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-25 [patent_title] => 'Targeted chromosomal genomic alterations in plants using modified single stranded oligonucleotides' [patent_app_type] => new [patent_app_number] => 10/307005 [patent_app_country] => US [patent_app_date] => 2002-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 39505 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20030236208.pdf [firstpage_image] =>[orig_patent_app_number] => 10307005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7469073 [patent_doc_number] => 20040102398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Modulation of B7H expression' [patent_app_type] => new [patent_app_number] => 10/303420 [patent_app_country] => US [patent_app_date] => 2002-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22850 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20040102398.pdf [firstpage_image] =>[orig_patent_app_number] => 10303420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7470550 [patent_doc_number] => 20040096836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Modulation of mitogen-activated protein kinase 13 expression' [patent_app_type] => new [patent_app_number] => 10/300642 [patent_app_country] => US [patent_app_date] => 2002-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20062 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20040096836.pdf [firstpage_image] =>[orig_patent_app_number] => 10300642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474193 [patent_doc_number] => 20040097450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Modulation of TDP-1 expression' [patent_app_type] => new [patent_app_number] => 10/300399 [patent_app_country] => US [patent_app_date] => 2002-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19964 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097450.pdf [firstpage_image] =>[orig_patent_app_number] => 10300399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474174 [patent_doc_number] => 20040097447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Modulation of interleukin 22 receptor expression' [patent_app_type] => new [patent_app_number] => 10/299089 [patent_app_country] => US [patent_app_date] => 2002-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20061 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097447.pdf [firstpage_image] =>[orig_patent_app_number] => 10299089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6843172 [patent_doc_number] => 20030148519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Intracellular expression and delivery of siRNAs in mammalian cells' [patent_app_type] => new [patent_app_number] => 10/294957 [patent_app_country] => US [patent_app_date] => 2002-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 33145 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20030148519.pdf [firstpage_image] =>[orig_patent_app_number] => 10294957 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6821261 [patent_doc_number] => 20030219422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Allosteric ribozymes and uses thereof' [patent_app_type] => new [patent_app_number] => 10/293477 [patent_app_country] => US [patent_app_date] => 2002-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13583 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20030219422.pdf [firstpage_image] =>[orig_patent_app_number] => 10293477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6822325 [patent_doc_number] => 20030220486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Mixed backbone oligonucleotides containing pops blocks to obtain reduced phosphorothioate content' [patent_app_type] => new [patent_app_number] => 10/291058 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3996 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20030220486.pdf [firstpage_image] =>[orig_patent_app_number] => 10291058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 274274 [patent_doc_number] => 07560438 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-14 [patent_title] => 'Genetic inhibition by double-stranded RNA' [patent_app_type] => utility [patent_app_number] => 10/283190 [patent_app_country] => US [patent_app_date] => 2002-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 19 [patent_no_of_words] => 14046 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/560/07560438.pdf [firstpage_image] =>[orig_patent_app_number] => 10283190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 299896 [patent_doc_number] => 07538095 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-26 [patent_title] => 'Genetic inhibition by double-stranded RNA' [patent_app_type] => utility [patent_app_number] => 10/282996 [patent_app_country] => US [patent_app_date] => 2002-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 19 [patent_no_of_words] => 14046 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/538/07538095.pdf [firstpage_image] =>[orig_patent_app_number] => 10282996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6966558 [patent_doc_number] => 20050233455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Acyclic linker-containing oligonucleotides and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/494141 [patent_app_country] => US [patent_app_date] => 2002-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16758 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20050233455.pdf [firstpage_image] =>[orig_patent_app_number] => 10494141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6801121 [patent_doc_number] => 20030096286 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Oligoribonucleotides and ribonucleases for cleaving RNA' [patent_app_type] => new [patent_app_number] => 10/280600 [patent_app_country] => US [patent_app_date] => 2002-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 32512 [patent_no_of_claims] => 93 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20030096286.pdf [firstpage_image] =>[orig_patent_app_number] => 10280600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5894787 [patent_doc_number] => 20060003326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Modified l-nucleic acid' [patent_app_type] => utility [patent_app_number] => 10/493569 [patent_app_country] => US [patent_app_date] => 2002-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 15003 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20060003326.pdf [firstpage_image] =>[orig_patent_app_number] => 10493569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6669423 [patent_doc_number] => 20030114407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Antisense modulation of G protein-coupled receptor ETBR-LP-2 expression' [patent_app_type] => new [patent_app_number] => 10/279186 [patent_app_country] => US [patent_app_date] => 2002-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26563 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20030114407.pdf [firstpage_image] =>[orig_patent_app_number] => 10279186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 536879 [patent_doc_number] => 07176295 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-13 [patent_title] => 'Systematic evolution of ligands by exponential enrichment: blended SELEX' [patent_app_type] => utility [patent_app_number] => 10/263456 [patent_app_country] => US [patent_app_date] => 2002-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 8398 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 171 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/176/07176295.pdf [firstpage_image] =>[orig_patent_app_number] => 10263456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7281241 [patent_doc_number] => 20040063618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Peptide nucleic acids having improved uptake and tissue distribution' [patent_app_type] => new [patent_app_number] => 10/261382 [patent_app_country] => US [patent_app_date] => 2002-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10357 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063618.pdf [firstpage_image] =>[orig_patent_app_number] => 10261382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6761901 [patent_doc_number] => 20030125263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Nucleic acid ligand complexes' [patent_app_type] => new [patent_app_number] => 10/261159 [patent_app_country] => US [patent_app_date] => 2002-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 23216 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20030125263.pdf [firstpage_image] =>[orig_patent_app_number] => 10261159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6655775 [patent_doc_number] => 20030077639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Ribozyme mediated inactivation of the androgen receptor' [patent_app_type] => new [patent_app_number] => 10/246078 [patent_app_country] => US [patent_app_date] => 2002-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18583 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20030077639.pdf [firstpage_image] =>[orig_patent_app_number] => 10246078 [rel_patent_id] =>[rel_patent_doc_number] =>)